The inaugural Gene Therapy Process Development Summit is a must-attend to discover the latest insights to bridge the gap between R&D and process development, ensuring that high-quality gene therapies are manufactured repeatably, at scale, and in a cost-effective manner.

Join us in Philadelphia to discover and learn the latest insights through case study presentations, informative panel discussions, and deep-dive workshops from Ultragenyx, REGENXBIO, Janssen, Amgen, Astellas Gene Therapies, and many more!

Whether you are looking to improve your platform processes or shorten development timelines this summit will be a unique opportunity to meet and network with peers to discuss successes and challenges in your process development journeys.

Join your peers to:

• Learn how to achieve the ideal complex size with Meira GTx by using automation and process analytical tools to optimize transient transfection leading to enhanced efficiency, time saving and scale-up insights
• Deep dive into enhancing the Pinnacle PCL Platform 2000L batch process with Ultragenyx to increase yield, improve product quality and reduce time-to-clinic
• Examine case study results with Astellas Gene Therapies and explore the optimization techniques to cut costs and streamline tech transfer and scale-up times
• Explore the design principles for creating robust AAV producer cell lines to yield a stable and consistent AAV production to optimize AAV vector generation to improve your platform processes with Lacerta and REGENXBIO
• Unpick the ever-changing, complex regulations surrounding the world of gene therapy in a detailed workshop that doubles down on development strategies that are adaptable to the challenges by gene therapy to prevent regulatory roadblocks when trying to get drugs to clinic

Download the full agenda here to see our full speaker faculty, 2-day agenda and audience breakdown: https://ter.li/nxp0nz